These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 19464737)
1. Evaluation of immunological status in tumor-bearing dogs. Itoh H; Horiuchi Y; Nagasaki T; Sakonju I; Kakuta T; Fukushima U; Uchide T; Yamashita M; Kuwabara M; Yusa S; Takase K Vet Immunol Immunopathol; 2009 Dec; 132(2-4):85-90. PubMed ID: 19464737 [TBL] [Abstract][Full Text] [Related]
2. Increase of regulatory T cells in the peripheral blood of dogs with metastatic tumors. Horiuchi Y; Tominaga M; Ichikawa M; Yamashita M; Jikumaru Y; Nariai Y; Nakajima Y; Kuwabara M; Yukawa M Microbiol Immunol; 2009 Aug; 53(8):468-74. PubMed ID: 19659931 [TBL] [Abstract][Full Text] [Related]
3. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles. Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609 [TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients. McCarter MD; Baumgartner J; Escobar GA; Richter D; Lewis K; Robinson W; Wilson C; Palmer BE; Gonzalez R Ann Surg Oncol; 2007 Oct; 14(10):2854-60. PubMed ID: 17593331 [TBL] [Abstract][Full Text] [Related]
7. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550 [TBL] [Abstract][Full Text] [Related]
8. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411 [TBL] [Abstract][Full Text] [Related]
9. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities. Kurt RA; Park JA; Panelli MC; Schluter SF; Marchalonis JJ; Carolus B; Akporiaye ET J Immunol; 1995 Apr; 154(8):3969-74. PubMed ID: 7706735 [TBL] [Abstract][Full Text] [Related]
10. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer. Biller BJ; Elmslie RE; Burnett RC; Avery AC; Dow SW Vet Immunol Immunopathol; 2007 Mar; 116(1-2):69-78. PubMed ID: 17224188 [TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133 [TBL] [Abstract][Full Text] [Related]
12. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917 [TBL] [Abstract][Full Text] [Related]
13. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood? Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447 [TBL] [Abstract][Full Text] [Related]
14. alpha beta T cell receptor-positive intraepithelial lymphocytes with CD4+, CD8- and CD4+, CD8+ phenotypes from orally immunized mice provide Th2-like function for B cell responses. Fujihashi K; Yamamoto M; McGhee JR; Kiyono H J Immunol; 1993 Dec; 151(12):6681-91. PubMed ID: 7903096 [TBL] [Abstract][Full Text] [Related]
15. Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity. Zou JP; Shimizu J; Ikegame K; Yamamoto N; Ono S; Fujiwara H; Hamaoka T J Immunol; 1992 Jan; 148(2):648-55. PubMed ID: 1345922 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. Tada T; Ohzeki S; Utsumi K; Takiuchi H; Muramatsu M; Li XF; Shimizu J; Fujiwara H; Hamaoka T J Immunol; 1991 Feb; 146(3):1077-82. PubMed ID: 1671050 [TBL] [Abstract][Full Text] [Related]
17. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2. Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359 [TBL] [Abstract][Full Text] [Related]
18. A novel immunotherapeutic modality with direct hemoperfusion targeting transforming growth factor-beta prolongs the survival of tumor-bearing rats. Yamamoto Y; Ueda Y; Itoh T; Iwamoto A; Yamagishi H; Shimagaki M; Teramoto K Oncol Rep; 2006 Dec; 16(6):1277-84. PubMed ID: 17089050 [TBL] [Abstract][Full Text] [Related]
19. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia. Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040 [TBL] [Abstract][Full Text] [Related]
20. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Ichihara F; Kono K; Takahashi A; Kawaida H; Sugai H; Fujii H Clin Cancer Res; 2003 Oct; 9(12):4404-8. PubMed ID: 14555512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]